Alkermes’ schizophrenia drug shows lower weight gain than comparator
The company plans to file a New Drug Application next year. An analyst wrote that it's unclear if the drug will require review by an advisory committee.
olanzapine
The company plans to file a New Drug Application next year. An analyst wrote that it's unclear if the drug will require review by an advisory committee.